World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
76
Citations
25177
World Ranking
1398
National Ranking
118

Overview

Mike Sharland is affiliated with St George's, University of London in the United Kingdom. Their research primarily spans the field of Medicine, with significant contributions in several interconnected subfields including Epidemiology, Applied Microbiology and Biotechnology, Public Health, Environmental and Occupational Health, Pharmacology, and Pediatrics, Perinatology and Child Health.

The main topics of Mike Sharland's work focus on Antibiotic Use and Resistance, Neonatal and Maternal Infections, Pneumonia and Respiratory Infections, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, Sepsis Diagnosis and Treatment, and Pharmaceutical studies and practices.

Recent notable publications by Mike Sharland include:

  • A living WHO guideline on drugs for covid-19, 2020, BMJ
  • Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data, 2020, The Lancet Infectious Diseases
  • The scope of the antimicrobial resistance challenge, 2024, The Lancet
  • The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance, 2023, Bulletin of the World Health Organization
  • Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review, 2020, Antimicrobial Resistance and Infection Control

Mike Sharland frequently publishes in several scientific venues where they have contributed multiple articles. The primary publication venues include:

  • Journal of Antimicrobial Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Microbiology and Infection
  • Antibiotics
  • Bulletin of the World Health Organization

Collaboration is a significant aspect of Mike Sharland's scientific activity. They have frequently co-authored work with several researchers, including:

  • Julia Bielicki (38 publications)
  • Sally Ellis (24 publications)
  • Aislinn Cook (20 publications)
  • Paul T. Heath (19 publications)
  • Yingfen Hsia (16 publications)

Best Publications

  • Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

    Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth

  • A living WHO guideline on drugs for covid-19

    Bram Rochwerg;Arnav Agarwal;Reed Ac Siemieniuk;Thomas Agoritsas

  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

    D. W. Kimberlin;P. M. Jester;P. J. Sánchez;A. Ahmed

  • Neonatal sepsis: an international perspective

    S Vergnano;M Sharland;P Kazembe;C Mwansambo

  • A clinical study of Noonan syndrome.

    M Sharland;M Burch;W M McKenna;M A Paton

  • Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.

    Eili Y Klein;Eili Y Klein;Maja Milkowska-Shibata;Katie K Tseng;Mike Sharland

  • Surveillance for control of antimicrobial resistance

    Evelina Tacconelli;Frangiscos Sifakis;Stephan Harbarth;Remco Schrijver

  • Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries

    Yingfen Hsia;Brian R Lee;Ann Versporten;Yonghong Yang

  • The scope of the antimicrobial resistance challenge

    Unknown

  • Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management.

    Suzanne E. Luck;Jantien W. Wieringa;Daniel Blázquez-Gamero;Philipp Henneke

  • Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics

    Natalie I Mazur;Federico Martinón-Torres;Eugenio Baraldi;Brigitte Fauroux

  • Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines.

    Uduak Okomo;Edem N K Akpalu;Kirsty Le Doare;Anna Roca

  • Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.

    D M Gibb;T Duong;P A Tookey;M Sharland

  • Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart—Then Focus

    Diane Ashiru-Oredope;Mike Sharland;Esmita Charani;Cliodna McNulty

  • The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.

    Ann Versporten;Julia Bielicki;Nico Drapier;Mike Sharland

  • Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.

    Ali Judd;Katja Doerholt;Pat A. Tookey;Mike Sharland

  • Potential for reducing inappropriate antibiotic prescribing in English primary care

    Timo Smieszek;Timo Smieszek;Koen B Pouwels;Koen B Pouwels;Koen B Pouwels;F Christiaan K Dolk;F Christiaan K Dolk;David R M Smith

  • Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients.

    Michael Burch;Michael Sharland;Elliot Shinebourne;Gillian Smith

  • Risk Factors for Hospital Admission with RSV Bronchiolitis in England: A Population-Based Birth Cohort Study

    Joanna Murray;Alex Bottle;Mike Sharland;Neena Modi

  • The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance

    Unknown

  • Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

    Mike Sharland;Celine Pulcini;Stéphan Juergen Harbarth;Mei Zeng

  • Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool

    Mike Sharland;Sumanth Gandra;Benedikt Huttner;Lorenzo Moja

  • Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance.

    Suman Chaurasia;Sindhu Sivanandan;Ramesh Agarwal;Sally Ellis

  • Empirical treatment of neonatal sepsis: are the current guidelines adequate?

    Berit Muller-Pebody;Alan Johnson;P. T. Heath;R. E. Gilbert

  • Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research.

    Elizabeth J A Fitchett;Anna C. Seale;Anna C. Seale;Stefania Vergnano;Michael Sharland

  • Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.

    Yingfen Hsia;Mike Sharland;Charlotte Jackson;Ian C K Wong;Ian C K Wong

  • Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey

    Walter Zingg;Walter Zingg;Susan Hopkins;Susan Hopkins;Angèle Gayet-Ageron;Alison Holmes;Alison Holmes

  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

    David W. Kimberlin;Penelope M. Jester;Pablo J. Sánchez;Amina Ahmed

Frequent Co-Authors

Paul T. Heath
Paul T. Heath St George's, University of London
Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Alan P. Johnson
Alan P. Johnson Public Health England
Ian C. K. Wong
Ian C. K. Wong University of Hong Kong
Diana M. Gibb
Diana M. Gibb University College London
Susanna Esposito
Susanna Esposito University of Parma
Herman Goossens
Herman Goossens University of Antwerp
Paul D. Griffiths
Paul D. Griffiths University College London
Carlo Giaquinto
Carlo Giaquinto University of Padua
Theoklis E. Zaoutis
Theoklis E. Zaoutis Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can broaden your career options within the field of microbiology. For individuals facing unique challenges, such as a criminal record, there are specialized programs like online colleges that accept felons, offering a fresh start through accessible education.

Healthcare remains a prominent career pathway connected to microbiology. For those interested in a clinical approach, becoming a functional medicine nurse practitioner combines patient care with a holistic understanding of health, emphasizing the microbial impact on the body.

On the administrative side, certifications like CPC certification prepare professionals to manage complex medical coding, which is integral to healthcare systems that often intersect with microbiology data and research.

Additionally, pursuing a master in health information management salary can lead to leadership roles that oversee critical health data systems, supporting advancements in microbiological research and public health initiatives.

Best Scientists Citing Mike Sharland

Trending Scientists

Recently Published Articles